Post

Sentiment towards Brexit has worsened three years after UK left EU

More than half (54%) of the surveyed healthcare industry professionals indicated that their sentiment towards Brexit had become more negative. …

Janssen submits NDA to FDA for PAH combination therapy

The Janssen Pharmaceutical Companies of Johnson & Johnson has submitted a new drug application (NDA) for its investigational single-tablet combination …

Stealth and Pharmanovia partner for commercialisation of elamipretide

Stealth BioTherapeutics has made an exclusive licensing agreement with Pharmanovia for the commercialisation of its elamipretide to treat Barth syndrome. Pharmanovia …

Betta to commercialise C4 Therapeutics’ CFT8919 in greater China

C4 Therapeutics has entered an exclusive licensing agreement with Betta Pharmaceuticals to develop and commercialise CFT8919 across the greater China …

XtalPi announces $250m AI drug discovery collaboration with Eli Lilly

XtalPi has made a partnership deal with US-based Eli Lilly to leverage artificial intelligence (AI) for drug discovery. XtalPi will receive …